Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
26 Jun, 2026, 12.19 PM IST
Rs 1 crore apartment becoming Rs 1.8 crore while selling is an illusion?: CA explains the hidden math of real estate profitsA property expert reveals a common 'math illusion' surrounding real estate gains. Many investors overlook significant expenses like stamp d...
26 Jun, 2026, 10.27 AM IST
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
26 Jun, 2026, 06.37 AM IST
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
25 Jun, 2026, 02.09 PM IST
India's growth story runs through waterIndia's ambitious industrial expansion faces a critical hurdle: water scarcity. As manufacturing's GDP contribution targets 25%, companies ...
24 Jun, 2026, 11.38 PM IST
Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
24 Jun, 2026, 01.16 PM IST
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
24 Jun, 2026, 01.16 AM IST
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
24 Jun, 2026, 01.03 AM IST
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
23 Jun, 2026, 08.03 PM IST
Tata Motors PV eyes over Rs 6 lakh crore revenue by FY31Tata Motors Passenger Vehicles is projecting a significant revenue surge, aiming to surpass Rs 6 lakh crore by fiscal year 2031 with a 10% ...
23 Jun, 2026, 02.48 PM IST
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
23 Jun, 2026, 12.05 PM IST
India's defence export boom could hit ₹65,000 crore by 2030; pvt sector startups the real play: Sunil SubramaniamIndia's defence exports are poised to surpass government targets, reaching ₹60,000-65,000 crore by 2030, according to market expert Sunil S...
23 Jun, 2026, 10.31 AM IST
DoT retains backhaul spectrum pricing, rejects Trai's cut proposalTelecom operators face continued high costs for backhaul spectrum as the Department of Telecommunications rejects regulator Trai's proposal...
23 Jun, 2026, 12.19 AM IST
Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
22 Jun, 2026, 08.48 AM IST
Dealmaking stays strong as startup M&A momentum carries into 2026Indian startups are experiencing a surge in M&A exits, particularly in consumer, fintech, and ecommerce sectors, signalling a robust recove...
22 Jun, 2026, 08.34 AM IST
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
22 Jun, 2026, 06.25 AM IST
NBFCs and private banks better positioned than PSU banks: Aman ChowhanAman Chowhan of Abakkus Asset Manager highlights crude oil as the dominant macro risk, potentially impacting corporate earnings by 100-200 ...
16 Jun, 2026, 01.23 PM IST